bpc-157 human studies safety adverse effects BPC-157: Tendon Repair and More The Hidden Risks of BPC‑157:

Peptide therapy is generally considered safe when administered by a trained professional

Steady state (Weeks 38): Continue the same daily dose

Doses are small, so syringe accuracy matters

30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)